|
original article |
Date |
Title |
Authors All Authors |
1 |
[GO] |
2022―Jul―12 |
The cross-over of statistical thinking and practices: A pandemic catalyst |
Andrew D. Garrett |
2 |
[GO] |
2022―Jul―12 |
Study-design in pandemics: From surveillance and performance-evaluation to licensing and pharmacovigilance |
Sheila M. Bird |
3 |
[GO] |
2020―Sep―17 |
The promise and pitfalls of composite endpoints in sepsis and COVID-19 clinical trials |
P. M. Brown, Tormod Rogne, Erik Solligård |